Tworoger SS - Search Results

1

Prospective Analysis of Circulating Biomarkers and Ovarian Cancer Risk in the UK Biobank.

Sasamoto N, Hathaway CA, Townsend MK, Terry KL, Trabert B, Tworoger SS. Sasamoto N, et al. Among authors: tworoger ss. Cancer Epidemiol Biomarkers Prev. 2024 Oct 2;33(10):1347-1355. doi: 10.1158/1055-9965.EPI-24-0319. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 39007864

2

Specimen allocation in longitudinal biomarker studies: controlling subject-specific effects by design.

Tworoger SS, Yasui Y, Chang L, Stanczyk FZ, McTiernan A. Tworoger SS, et al. Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1257-60. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15247140 Clinical Trial.

3

Plasma prolactin concentrations and risk of postmenopausal breast cancer.

Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE. Tworoger SS, et al. Cancer Res. 2004 Sep 15;64(18):6814-9. doi: 10.1158/0008-5472.CAN-04-1870. Cancer Res. 2004. PMID: 15375001

4

Intake of folate and related nutrients in relation to risk of epithelial ovarian cancer.

Tworoger SS, Hecht JL, Giovannucci E, Hankinson SE. Tworoger SS, et al. Am J Epidemiol. 2006 Jun 15;163(12):1101-11. doi: 10.1093/aje/kwj128. Epub 2006 Mar 22. Am J Epidemiol. 2006. PMID: 16554344

5

The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.

Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, Barbieri RL, Hankinson SE. Tworoger SS, et al. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):967-71. doi: 10.1158/1055-9965.EPI-05-0976. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16702378

6

A prospective study of postmenopausal hormone use and ovarian cancer risk.

Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE. Danforth KN, et al. Among authors: tworoger ss. Br J Cancer. 2007 Jan 15;96(1):151-6. doi: 10.1038/sj.bjc.6603527. Epub 2006 Dec 19. Br J Cancer. 2007. PMID: 17179984 Free PMC article.

7

Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.

Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE. Eliassen AH, et al. Among authors: tworoger ss. Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):161-4. doi: 10.1158/1055-9965.EPI-06-0693. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17220346

8

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.

Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE. Tworoger SS, et al. Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):783-8. doi: 10.1158/1055-9965.EPI-06-0981. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17416771

9

A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer.

Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE. Gates MA, et al. Among authors: tworoger ss. Int J Cancer. 2007 Nov 15;121(10):2225-32. doi: 10.1002/ijc.22790. Int J Cancer. 2007. PMID: 17471564 Clinical Trial.

10

Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.

Tworoger SS, Fairfield KM, Colditz GA, Rosner BA, Hankinson SE. Tworoger SS, et al. Am J Epidemiol. 2007 Oct 15;166(8):894-901. doi: 10.1093/aje/kwm157. Epub 2007 Jul 26. Am J Epidemiol. 2007. PMID: 17656616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

415 results

Search Page

Filters